Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$1.22 - $5.24 $4,959 - $21,300
4,065 New
4,065 $5,000
Q1 2023

May 17, 2023

SELL
$4.89 - $10.53 $4,748 - $10,224
-971 Reduced 73.28%
354 $2,000
Q4 2022

Feb 13, 2023

BUY
$3.86 - $42.0 $5,114 - $55,650
1,325 New
1,325 $10,000
Q3 2021

Nov 05, 2021

SELL
$6.69 - $16.93 $2,174 - $5,502
-325 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$10.57 - $21.61 $3,435 - $7,023
325 New
325 $6,000

Others Institutions Holding BIVI

About BIOVIE INC.


  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $92M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.